Pharma Stocks
-
Oscar Health (OSCR) Nears 52-Week High on Pharma Tariff Pause
We recently published 10 Stocks With Eye-Popping Double-Digit Gains. Oscar Health Inc. (NYSE:OSCR) is one of the top performers on…
Read More » -
Japanese Pharma Stocks Surge Amid Influenza Outbreak
In 2025, Japan faces a significant influenza outbreak, leading to a notable surge in demand for flu vaccines. This situation…
Read More » -
Will Herantis Pharma Oyj (HEL:HRTIS) Spend Its Cash Wisely?
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years…
Read More » -
A Fresh Look at Ascendis Pharma (NasdaqGS:ASND) Valuation as Shareholder Returns Turn Positive
Ascendis Pharma (NasdaqGS:ASND) has seen its share price fluctuate recently, but returns over the past month and 3 months are…
Read More » -
A Look at Ionis Pharmaceuticals’s Valuation as Zilganersen Trial Delivers Landmark Results for Alexander Disease
Ionis Pharmaceuticals (IONS) reported positive topline results from its pivotal trial of zilganersen for Alexander disease, showing clear disease stabilization.…
Read More » -
Teva (NYSE:TEVA) Valuation in Focus as Analyst Upgrades and Innovation Strategy Boost Outlook
Teva Pharmaceutical Industries (NYSE:TEVA) stock has caught fresh attention as several analysts recently raised earnings estimates, citing encouraging data from…
Read More » -
Grippewelle Concerns Trigger Surge in Pharma Stocks as Germany Prepares
Germany’s flu season, known as “grippewelle,” is drawing heightened attention amidst predictions of a severe outbreak. This has spurred increased…
Read More » -
Vertex Pharmaceuticals (VRTX) Highlights Pipeline Progress at BofA Global Healthcare Conference
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks among the best biotech stocks to buy. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) participated in the Bank…
Read More » -
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
Shares of AstraZeneca (NASDAQ: AZN) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results…
Read More » -
Revenues Not Telling The Story For Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) After Shares Rise 28%
Despite an already strong run, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) shares have been powering on, with a gain of 28% in…
Read More »